Needlestick organisation urges primary prevention
This article was originally published in Clinica
A needlestick safety organization funded by the device industry is calling for a shift in federal health policy on how to prevent sharps injuries. The National Alliance for the Primary Prevention of Sharps Injuries (NAPPSI) contends that government officials have put too much emphasis on a secondary prevention strategy - the need to use safer needles. Instead, they argue, officials should put at least equal emphasis on primary prevention strategies by advocating technologies or practices that do not require the use of sharps in the first place.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.